(nintedanib OR BIBF 1120 OR VEGFR inhibitor) AND (chemotherapy OR antineoplastic) AND (lung neoplasms OR non-small cell lung cancer OR small cell lung cancer). This evidence concerns the gene KDR and small cell lung carcinoma.